Nevro (NVRO) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Nevro Reports Fourth Quarter and Full Year 2015 Financial Results
February 29, 2016 4:09 PM ESTREDWOOD CITY, Calif., Feb. 29, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three months and full year ended December 31, 2015.
2015 Accomplishments & Highlights:
Achieved revenue of $69.6 million for the full year 2015, an increase of 114% as reported, over the prior year U.S. revenue of $24.3 million for 2015 International revenue of $45.3 million for 2015, an increase of 62% constant currency and 39% as reported,... More